INSIDER · CIK 1897557
Barrow Robert
Chief Executive Officer, Director at Definium Therapeutics, Inc. (DFTX)
↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.9MSold on the market
1Companies
Sep 29, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 202621:14 | Sep 25, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $36.57 | −31,550 | 2,213,090 | -1% | −$1.2M | ||
| Sep 14, 202608:30 | Sep 14, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Executive Officer, Director | A · Grant | — | +750,000 | 2,244,640 | +50% | — | ||
| Sep 4, 202621:30 | Sep 3, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $37.94 | −19,023 | 1,494,640 | -1% | −$722K | ||
| Sep 4, 202621:30 | Sep 2, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Executive Officer, Director | A · Grant10b5-1 | — | +40,000 | 1,513,663 | +3% | — | ||
| Aug 12, 202608:30 | Aug 12, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Executive Officer, Director | A · Grant | — | +375,000 | 1,473,246 | +34% | — |